"...75%...next week." Seethamraju. No doubt, an
Post# of 154359
No doubt, an inaccurate statement, but I'd say he probably meant that the 75%, the enrollment of 293, could ("possibly"

The trial for severe-to-critical Covid-19 patients, which costs about $9 million, has recruited 247 of its targeted 390 patients, Pourhassan said. The FDA has agreed to review its efficacy results at the 75% recruitment point, which could be hit as soon as next week, Seethamraju said. [...]"

